✦ LIBER ✦

On-demand treatment of bleeds in haemophilia patients with inhibitors: strategies for securing and maintaining predictable efficacy with recombinant activated factor VII

✍ Scribed by B. SØRENSEN; Y. DARGAUD; G. KENET; J. LUSHER; A. MUMFORD; S. PIPE; A. TIEDE

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Single-dose (270 μg kg−1) recombinant ac

✍ B. PAN-PETESCH; P. LAGUNA; A. MITAL; J. STANLEY; M. F. TORCHET; S. Z. SALEK; P. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Efficacy of recombinant activated factor

✍ M. J. TREUR; F. MCCRACKEN; B. HEEG; A. V. JOSHI; M. F. BOTTEMAN; F. DE CHARRO; B 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 330 KB

Recombinant activated factor VII safety

✍ C. NAKAR; D. L. COOPER; D. DiMICHELE 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB

Clinical observation on safety and effic

✍ L. ZHANG; Y. ZHAO; J. SUN; X. WANG; M. YU; R. YANG 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

Six-month clinical observation on safety

✍ L. ZHANG; Y. ZHAO; J. SUN; X. WANG; J. WU; M. YU; R. YANG 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB